Back

Myocardial delivery of a mitochondria-targeted H₂S donor restores bioenergetics and cardiac performance in diabetic cardiomyopathy

30 August 2026 (15:18 - 15:30)
Organised by: Logo
Congress Presentation Part of: Mitochondrial function and metabolic remodelling in heart disease Cardiomyopathies ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Yuxiu Yang

Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)

4 More presentations in this session

Presentation thumbnail
Von Willebrand factor a domain containing 8 (VWA8) is a mitochondria–ER spacer that restrains β-adrenergic–induced cardiac hypertrophy
Doctor H. Fan (Padova, IT)
Abstract Slides Video
Presentation thumbnail
SPAK regulates myocardial chloride homeostasis and drives dilated cardiomyopathy through mitochondrial dysfunction and energy metabolic disruption
Doctor S. Zhang (Xiamen, CN)
Abstract Slides Video
Presentation thumbnail
BHB-mediated ANT1 kbhb modification couples mitochondrial homeostasis to inflammatory suppression in ischaemic heart failure
Doctor A. Chen (Shanghai, CN)
Presentation thumbnail
TMEM65 ameliorates post-myocardial infarction heart failure by maintaining mitochondrial calcium homeostasis via inhibiting NCLX ubiquitination
Doctor S. Li (Nanjing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Mitochondrial function and metabolic remodelling in heart disease
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 15:18 CET
You may be interested in
thumbnail
Congress Presentation
Impact of oxygen deficiency on changes in respiratory chain proteins and membrane potential of cardiac mitochondria
29 June 2021
thumbnail
Congress Session
New frontiers in heart failure therapies
19 May 2025
thumbnail
Congress Presentation
Cardiac diastolic dysfunction in angiotensin II-treated hypertensive rats is associated with endothelial upregulation of SGLT1/2 in the macro and microcirculation: Protective effect of empagliflozin
29 June 2021
thumbnail
Congress Presentation
Proteomics profiling reveals distinct molecular subtypes of hypertrophic cardiomyopathy with differential risks of major adverse cardiovascular events
28 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources